Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs PARENT.DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA PARENT.DRUGS DISHMAN PHARMA/
PARENT.DRUGS
 
P/E (TTM) x 30.0 -0.1 - View Chart
P/BV x 3.3 - - View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   PARENT.DRUGS
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
PARENT.DRUGS
Mar-21
DISHMAN PHARMA/
PARENT.DRUGS
5-Yr Chart
Click to enlarge
High Rs3743 11,810.7%   
Low Rs1293 4,957.7%   
Sales per share (Unadj.) Rs197.04.1 4,827.8%  
Earnings per share (Unadj.) Rs21.2-40.8 -51.9%  
Cash flow per share (Unadj.) Rs34.7-35.0 -99.1%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.9-229.0 -78.5%  
Shares outstanding (eoy) m80.7029.82 270.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.7 180.7%   
Avg P/E ratio x11.9-0.1 -16,803.4%  
P/CF ratio (eoy) x7.3-0.1 -8,799.3%  
Price / Book Value ratio x1.40 -11,106.2%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,30786 23,607.8%   
No. of employees `000NANA-   
Total wages/salary Rs m5,355145 3,690.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898122 13,065.2%  
Other income Rs m2651 41,468.8%   
Total revenues Rs m16,163122 13,214.9%   
Gross profit Rs m4,103-118 -3,485.3%  
Depreciation Rs m1,091173 629.5%   
Interest Rs m9441,254 75.3%   
Profit before tax Rs m2,334-1,545 -151.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-328 -190.4%   
Profit after tax Rs m1,710-1,217 -140.5%  
Gross profit margin %25.8-96.8 -26.7%  
Effective tax rate %26.721.2 126.0%   
Net profit margin %10.8-1,000.3 -1.1%  
BALANCE SHEET DATA
Current assets Rs m11,018681 1,618.5%   
Current liabilities Rs m9,51711,436 83.2%   
Net working cap to sales %9.4-8,839.3 -0.1%  
Current ratio x1.20.1 1,945.0%  
Inventory Days Days57375 15.2%  
Debtors Days Days30-  
Net fixed assets Rs m18,7873,343 562.0%   
Share capital Rs m161298 54.1%   
"Free" reserves Rs m14,354-7,127 -201.4%   
Net worth Rs m14,516-6,829 -212.6%   
Long term debt Rs m4,1891,072 390.8%   
Total assets Rs m29,8054,024 740.7%  
Interest coverage x3.5-0.2 -1,499.5%   
Debt to equity ratio x0.3-0.2 -183.9%  
Sales to assets ratio x0.50 1,763.8%   
Return on assets %8.90.9 962.4%  
Return on equity %11.817.8 66.1%  
Return on capital %17.55.0 347.5%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m594NA-   
Fx inflow Rs m4,9520-   
Fx outflow Rs m6970-   
Net fx Rs m4,2550-   
CASH FLOW
From Operations Rs m2,7861,253 222.3%  
From Investments Rs m-1,5291 -246,596.8%  
From Financial Activity Rs m-941-1,254 75.0%  
Net Cashflow Rs m317-1 -62,058.8%  

Share Holding

Indian Promoters % 61.4 73.3 83.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 0.0 229,500.0%  
FIIs % 12.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 26.7 144.5%  
Shareholders   52,291 7,129 733.5%  
Pledged promoter(s) holding % 0.0 94.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs PARENT.DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs PARENT.DRUGS Share Price Performance

Period Dishman Pharma PARENT.DRUGS S&P BSE HEALTHCARE
1-Day 2.87% 4.63% 1.23%
1-Month -2.45% 9.71% -0.24%
1-Year 96.38% -19.48% 43.62%
3-Year CAGR 89.34% 8.97% 20.35%
5-Year CAGR 38.20% -19.84% 26.24%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the PARENT.DRUGS share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of PARENT.DRUGS the stake stands at 73.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of PARENT.DRUGS.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

PARENT.DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of PARENT.DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.